Agile Therapeutics soars after Maxim raises rating to 'buy'

Agile Therapeutics

22/09/2023 15:28

** Shares of Agile Therapeutics  AGRX.O  rise 6.5% to $1.84;
set to snap four-day losing streak 
    ** Brokerage Maxim upgrades stock's rating to "buy" from
"hold" and establishes a 12-month PT of $5 
    ** Maxim says it sees "faster-than-expected demand growth"
for Twirla, co's birth control patch for women
    ** Up to last close of $1.73, shares down 83.1% YTD

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))